圣达生物：1784.07万股限售股12月25日上市流通

Core Viewpoint - The company announced that 17,840,700 restricted shares will be listed for trading on December 25, 2025, representing 9.44% of the total share capital [1] Group 1 - The company completed the registration of A-share issuance to specific targets on June 25, 2025, increasing the total share capital from 171,188,958 shares to 189,029,624 shares [1] - All shareholders of the restricted shares have committed to not transferring their shares within six months from the end of the issuance [1] - The sponsoring institution has no objections regarding the listing of the restricted shares [1]